Aberdeen Asset Management’s Zimmer Biomet ZBH Stock Holding History

Aberdeen Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$6.1M	Buy	48,930 +3,085	+7%	+$366K	0.02%	429
2017 Q1	$5.43M	Buy	45,845 +5,035	+12%	+$571K	0.02%	442
2016 Q4	$4.09M	Sell	40,810 -1,855	-4%	-$199K	0.02%	470
2016 Q3	$5.38M	Buy	42,665 +3,942	+10%	+$487K	0.02%	423
2016 Q2	$4.53M	Buy	38,723 +203	+0.5%	+$23K	0.02%	434
2016 Q1	$3.99M	Sell	38,520 -689	-2%	-$66.7K	0.01%	454
2015 Q4	$3.59M	Buy	39,209 +6,208	+19%	+$607K	0.01%	473
2015 Q3	$3.01M	Sell	33,001 -13,265	-29%	-$1.33M	0.01%	453
2015 Q2	$4.9M	Sell	46,266 -2,615	-5%	-$289K	0.01%	390
2015 Q1	$5.58M	Sell	48,881 -2,764	-5%	-$315K	0.02%	363
2014 Q4	$5.69M	Sell	51,645 -19,187	-27%	-$2.02M	0.01%	351
2014 Q3	$6.92M	Sell	70,832 -4,826	-6%	-$475K	0.02%	363
2014 Q2	$7.63M	Buy	75,658 +57,105	+308%	+$5.57M	0.02%	375
2014 Q1	$1.7M	Sell	18,553 -309	-2%	-$28.5K	﹤0.01%	365
2013 Q4	$1.69M	Hold	18,862	–	–	﹤0.01%	342
2013 Q3	$1.5M	Sell	18,862 -464	-2%	-$36.5K	﹤0.01%	358
2013 Q2	$1.41M	Buy	+19,326	New	+$1.45M	﹤0.01%	371

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Aberdeen Asset Management's ZBH Position: Q2 2017 in Review

Aberdeen Asset Management increased its Zimmer Biomet (ZBH) stake by 6.7% in Q2 2017, buying an estimated $366K and bringing the position to 48,930 shares worth $6.1M. The position accounts for 0.02% of the portfolio, ranked #429.

Aberdeen Asset Management first reported a position in ZBH in Q2 2013 and has held it in 17 quarters since. The position peaked at $7.63M in Q2 2014. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

Aberdeen Asset Management held 48,930 shares of Zimmer Biomet worth $6.1M as of Q2 2017.
Aberdeen Asset Management bought 3,085 Zimmer Biomet shares in Q2 2017, an estimated $366K.
Zimmer Biomet made up 0.02% of Aberdeen Asset Management's portfolio in Q2 2017, its #429 holding.
Aberdeen Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Zimmer Biomet position peaked at $7.63M in Q2 2014.
819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.